Mitsubishi Tanabe Pharma - About the company
Mitsubishi Tanabe Pharma is an acquired company based in Osaka (Japan), founded in 1678. It operates as a Pharmaceutical company specializing in the development of innovative therapies and drugs. The company has 729 active competitors, including 42 funded and 69 that have exited. Its top competitors include companies like Pharmaron, Lonza and Pfizer.
Company Details
Mitsubishi Tanabe Pharma Corporation is a Japanese pharmaceutical company based in Osaka. They are involved in research and development of innovative therapies and have a pipeline of investigational therapies. They also collaborate with other companies for joint development projects.
Key Metrics
Founded Year
1678
Location
Osaka, Japan
Stage
Acquired
Ranked
13th among
Investment & Acquisitions
Similar Companies
Exit Details
Acquired by Bain Capital (Feb 07, 2025)
Mitsubishi Tanabe Pharma's acquisition details
Mitsubishi Tanabe Pharma got acquired by Bain Capital on Feb 07, 2025. It was facilitated by MUFG, Morrison & Foerster, Mori Hamada & Matsumoto and .
Click to take a look at Mitsubishi Tanabe Pharma's acquisition in detail
Mitsubishi Tanabe Pharma's funding and investors
Mitsubishi Tanabe Pharma is a funded company.
Access 秘密研究所 on any website
Our Google Chrome extension lets you view company details while browsing their websites
Mitsubishi Tanabe Pharma's Competitors and alternates
Top competitors of Mitsubishi Tanabe Pharma include Pharmaron, Lonza and Pfizer. Here is the list of Top 10 competitors of Mitsubishi Tanabe Pharma, ranked by 秘密研究所 score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | 秘密研究所 Score |
|---|---|---|---|---|---|
1st | Suite of drug discovery and development services for small molecules | $320M | Aisling Capital, Scientia Ventures听&补尘辫;听 | 75/100 | |
2nd | Lonza 1897, Basel (Switzerland), Acquired | Provider of CDMO services to pharma, biotech, and specialty ingredient markets | - | 67/100 | |
3rd |  Pfizer 1849, New York City (United States), Public | Provider of pharmaceutical products for multiple disease treatments | - | Tekla Capital Management, 听&补尘辫;听 | 67/100 |
4th |  Boehringer Ingelheim 1885, Ingelheim am Rhein (Germany), Funding Raised | Provider of generic drugs and clinical research services | - | 64/100 | |
5th |  Tyra 2018, Carlsbad (United States), Public | Developer of cancer resistance therapies | $156M | Alta Partners, BVF Partners听&补尘辫;听 | 57/100 |
6th |  LabConnect 2002, Johnson City (United States), Series A | Provider of laboratory testing, clinical ttrial research, and biopharma functional services | $29.2M | ABS Capital, CYwP Funds听&补尘辫;听 | 55/100 |
7th |  Ainos 1986, San Diego (United States), Public | Company focused on the development of novel point-of-care testing and low-dose interferon therapeutics | - | The Lind Partners, 听&补尘辫;听 | 53/100 |
8th |  Beta Drugs 2005, Panchkula (India), Public | Developer of therapeutics for oncology and dermatology | - | 52/100 | |
9th |  2018, Vilnius (Lithuania), Seed | Provider of synthetic biology and AI-based technology for generative protein design | $7.73M | Metaplanet, Inventure听&补尘辫;听 | 51/100 |
10th |  Ichor Life Sciences 2013, Manhattan (United States), Seed | Provider of premium laboratory CRO services to biotechnology and research organizations | $3.45M | 48/100 | |
13th |  1678, Osaka (Japan), Acquired | Pharmaceutical company specializing in the development of innovative therapies and drugs | - | - | 44/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Mitsubishi Tanabe Pharma's competitors? Click to see the top ones
Mitsubishi Tanabe Pharma's Investments and acquisitions
Mitsubishi Tanabe Pharma has made 1 investment in Cytochroma and acquired NeuroDerm and Medicago. Here is the list of these investments and acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jul 24, 2017 | Acquisition | 2003 | Ness Ziona, | |
Jul 12, 2013 | Acquisition | 1999 | Quebec City, Canada | |
Jul 30, 2008 | Investments | 1996 | Bannockburn, |
Want to know more about where corporates are investing? Sign up today!Reports related to Mitsubishi Tanabe Pharma
Here is the latest report on Mitsubishi Tanabe Pharma's sector:
View
News related to Mitsubishi Tanabe Pharma
Media has covered Mitsubishi Tanabe Pharma for a total of 17 events in the last 1 year, 5 of them have been about partnerships and 3 about company updates.
鈥�
鈥�
The Business Times鈥�Mar 03, 2025鈥�Blackstone, CMiC, Bain Capital, Mitsubishi Tanabe Pharma and 1 other
鈥�
chemengonline.com鈥�Feb 11, 2025鈥�Mitsubishi Chemical Group, Mitsubishi Tanabe Pharma, Bain Capital Private Equity
鈥�
鈥�
PE Hub鈥�Feb 07, 2025鈥�Bain Capital, Mitsubishi Tanabe Pharma, Mitsubishi Chemical Group, Mitsubishi and 2 others
鈥�
Shareandstocks鈥�Feb 06, 2025鈥�Mitsubishi Tanabe Pharma, Bain & Company, Bain Capital, Mitsubishi Chemical Group
鈥�
鈥�
鈥�
Indiatimes鈥�Dec 13, 2024鈥�Blackstone, Bain Capital, Mitsubishi Tanabe Pharma, Mitsubishi Chemical Group and 1 other
鈥�
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQ's about Mitsubishi Tanabe Pharma
Explore our recently published companies
- Verbeeminstallaties.nl - Netherlands based, Unfunded company
- Tamiya - Shizuoka based, 1946 founded, Unfunded company
- Stratiom - Winchester based, 2025 founded, Unfunded company
